West Announces Quarterly Dividend and Share Repurchase Program

West (NYSE: WST) declared a $0.22 per share regular quarterly dividend payable May 6, 2026, to shareholders of record on April 29, 2026.

Rhea-AI Summary

West (NYSE: WST) declared a $0.22 per share regular quarterly dividend payable May 6, 2026, to shareholders of record on April 29, 2026. The board also authorized a new $1.0 billion share repurchase program on February 17, 2026, with no expiration date.

Repurchases may occur on the open market, via pre-set trading plans, in negotiated transactions, or other lawful methods; the program is discretionary and may be suspended or terminated. The prior program was fully utilized before its December 31, 2025 expiration.

Positive

• Quarterly dividend of $0.22 per share declared
• $1.0 billion authorized share repurchase program
• Repurchase program has no expiration date, offering flexibility

Negative

• Repurchases are discretionary and not guaranteed
• No specified timeline or minimum repurchase amount could delay impact

Argus Feb 18 session

+2.08% close to close Open Argus

Details

News Market Reaction – WST

On Feb 18, the first trading day after this news, WST closed 2.08% above the previous close.

Data tracked by StockTitan Argus for the Feb 18 session.

Market Context

This announcement highlights continued capital returns via a regular $0.22 quarterly dividend and a ...

Analysis

This announcement highlights continued capital returns via a regular $0.22 quarterly dividend and a new authorization to repurchase up to $1 billion of common stock, following full utilization of the prior program by December 31, 2025. Together with recently reported earnings strength and cash generation, it underscores an ongoing commitment to returning cash to shareholders. Investors may watch execution of the repurchase program and future dividend actions alongside operating performance.

Key Figures

Quarterly dividend: $0.22 per share Buyback authorization: $1 billion Dividend payment date: May 6, 2026 +2 more

Quarterly dividend

$0.22 per share

Regular quarterly dividend declared Feb 16, 2026

Buyback authorization

$1 billion

Maximum under new share repurchase program

Dividend payment date

May 6, 2026

Payable date for declared quarterly dividend

Dividend record date

April 29, 2026

Shareholders of record eligible for dividend

Prior program expiry

December 31, 2025

Previous repurchase program fully utilized before expiry

Historical Context

5 past events · Latest: Feb 12

5 events

1. Feb 12

   Earnings results

   24h Move

   -1.0%

   Reported strong Q4 and FY2025 growth with higher sales, EPS, and cash flow.

2. Jan 29

   Earnings call setup

   24h Move

   -1.4%

   Announced timing and access details for Q4 and FY2025 earnings call.

3. Jan 20

   Product launch

   24h Move

   -3.6%

   Introduced Synchrony S1 prefillable syringe system with multiple configuration options.

4. Jan 12

   Asset sale

   24h Move

   -0.9%

   AbbVie agreed to acquire West’s Tempe device facility and related IP.

5. Jan 12

   Asset sale

   24h Move

   -0.9%

   Agreed to sell SmartDose 3.5mL manufacturing and supply rights to AbbVie.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

share repurchase program

1 terms

share repurchase program financial

"the Board of Directors authorized a new share repurchase program for the purchase of up to $1 billion"

A share repurchase program is when a company buys back its own shares from the marketplace. This reduces the total number of shares available, which can increase the value of each remaining share and signal confidence in the company's prospects. For investors, it often suggests that the company believes its stock is undervalued or that it has extra cash to return to shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

EXTON, Pa., Feb. 17, 2026 /PRNewswire/ -- On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, declared its regular quarterly dividend of $0.22 per share on the Company's common stock. The dividend is payable on May 6, 2026 to shareholders of record on April 29, 2026.

On February 17, 2026, the Board of Directors authorized a new share repurchase program for the purchase of up to $1 billion of the Company's common stock.

The number of shares to be repurchased and the timing of any repurchases will depend on factors such as the stock price, economic and market conditions, and corporate and regulatory requirements. The Company may repurchase shares of its common stock from time to time on the open market (including via pre-set trading plans), in privately negotiated transactions, or through other transactions in accordance with applicable securities laws. The share repurchase program does not obligate the Company to acquire any particular amount of common stock, has no expiration date, and it may be suspended or terminated at any time.

The Company's previous share repurchase program was fully utilized prior to its December 31, 2025, expiration.

About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life saving and life enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.  

Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com. 

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-quarterly-dividend-and-share-repurchase-program-302689836.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What dividend did West (WST) declare on February 16, 2026?

West declared a $0.22 per share regular quarterly dividend. According to the company, the dividend is payable May 6, 2026, to shareholders of record on April 29, 2026.

How large is West's (WST) new share repurchase program announced February 17, 2026?

West authorized a $1.0 billion share repurchase program. According to the company, purchases may occur on the open market, through negotiated transactions, or via pre-set trading plans.

When will West (WST) pay the declared dividend in 2026?

The declared dividend is payable on May 6, 2026. According to the company, the record date for shareholders eligible to receive the dividend is April 29, 2026.

Does West's (WST) $1.0 billion buyback program have an end date?

The $1.0 billion repurchase program has no expiration date. According to the company, the program may be suspended, terminated, or adjusted based on market and corporate conditions.

How might West (WST) execute share repurchases under the new program?

West may repurchase shares on the open market, via pre-set trading plans, or in negotiated transactions. According to the company, timing and amounts will depend on stock price and market conditions.